<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Dandelion Studies Summary</title>
  <style>
    :root {
      --primary-color: #4a7c59;
      --secondary-color: #f4d35e;
      --text-color: #333;
      --light-bg: #f9f9f7;
      --accent-color: #ee964b;
    }
    
    body {
      font-family: Arial, sans-serif;
      margin: 0;
      line-height: 1.5;
      color: var(--text-color);
      background-color: var(--light-bg);
    }
    
    .container {
      max-width: 1200px;
      margin: 0 auto;
      padding: 0 20px;
    }
    
    header {
      background-color: var(--primary-color);
      color: white;
      padding: 1rem 0;
      box-shadow: 0 2px 5px rgba(0,0,0,0.1);
    }
    
    nav {
      display: flex;
      justify-content: space-between;
      align-items: center;
    }
    
    .logo {
      font-size: 1.5rem;
      font-weight: bold;
    }
    
    .nav-links {
      display: flex;
      list-style: none;
    }
    
    .nav-links li {
      margin-left: 1.5rem;
    }
    
    .nav-links a {
      color: white;
      text-decoration: none;
      font-weight: 500;
      transition: color 0.3s;
    }
    
    .nav-links a:hover {
      color: var(--secondary-color);
    }
    
    .content-area {
      padding: 20px;
    }
    
    h1 {
      font-size: 1.8em;
      margin-bottom: 15px;
      color: var(--primary-color);
    }
    
    table {
      width: 100%;
      border-collapse: collapse;
      margin-top: 15px;
      background-color: white;
      box-shadow: 0 1px 3px rgba(0,0,0,0.1);
    }
    
    th, td {
      border: 1px solid #ccc;
      padding: 10px;
      vertical-align: top;
      text-align: left;
    }
    
    th {
      background-color: #f4f4f4;
      font-weight: bold;
    }
    
    tr:nth-child(even) {
      background-color: #fafafa;
    }
    
    code {
      white-space: pre-wrap;
      font-family: monospace;
      background-color: #f9f9f9;
      padding: 2px 4px;
      border-radius: 4px;
    }
    
    .references {
      margin-top: 30px;
      font-size: 0.9em;
      padding: 15px;
      background-color: white;
      border-radius: 5px;
      box-shadow: 0 1px 3px rgba(0,0,0,0.1);
    }
    
    .references h2 {
      font-size: 1.3em;
      margin-bottom: 10px;
      color: var(--primary-color);
    }
    
    .references ul {
      padding-left: 20px;
    }
    
    .references li {
      margin-bottom: 8px;
    }
    
    footer {
      background-color: var(--primary-color);
      color: white;
      padding: 1rem 0;
      text-align: center;
      margin-top: 30px;
    }
    
    .extraction-link {
      display: inline-block;
      margin: 20px 0;
      background-color: var(--secondary-color);
      color: var(--text-color);
      padding: 0.8rem 1.5rem;
      text-decoration: none;
      border-radius: 4px;
      font-weight: bold;
      transition: background-color 0.3s;
    }
    
    .extraction-link:hover {
      background-color: var(--accent-color);
    }
    
    @media (max-width: 768px) {
      .nav-links {
        display: none;
      }
    }
  </style>
</head>
<body>
  <header>
    <div class="container">
      <nav>
        <div class="logo">Plant Medicine</div>
        <ul class="nav-links">
          <li><a href="index.html">Home</a></li>
          <li><a href="dandelion.html">Dandelion</a></li>
          <li><a href="dandlion_extracts.html">Extraction Methods</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <div class="container content-area">
    <h1>Dandelion Studies Summary</h1>
    <a href="dandlion_extracts.html" class="extraction-link">View Dandelion Extraction Methods</a>
  <table>
    <thead>
      <tr>
        <th>Study (Reference)</th>
        <th>Model (Cell/Animal/Human)</th>
        <th>Extract Details &amp; Concentration</th>
        <th>Duration</th>
        <th>Outcome (Efficacy)</th>
        <th>Conclusion</th>
      </tr>
    </thead>
    <tbody>
      <tr>
        <td>
          Shittu et al. “Antioxidant and antimicrobial activities of Dandelion root extract (Taraxacum officinale) and its cytotoxic effect on MDA-MB-231 breast cancer cells” (2025)
        </td>
        <td>
          MDA-MB-231 human breast cancer cells (in vitro)
        </td>
        <td>
          <strong>Type:</strong> Aqueous Dandelion Root Extract (DRE)<br>
          <strong>Preparation:</strong> Fresh roots collected, shade-dried, powdered, macerated in distilled water, filtered, lyophilized into powder.<br>
          <strong>Concentrations Tested:</strong> 1.0, 2.5, 5.0, 10 mg/mL (reconstituted from lyophilized powder)
        </td>
        <td>
          24 h, 48 h, 72 h
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li><strong>IC₅₀ values</strong> (mg/mL):<br>
              • 24 h: 4.472 mg/mL<br>
              • 48 h: 4.167 mg/mL (↓ 6.8 % vs. 24 h)<br>
              • 72 h: 3.450 mg/mL (↓ 17.2 % vs. 48 h)
            </li>
            <li>Dose-dependent reduction in viability observed by trypan-blue exclusion; at 5 mg/mL, ~50 % cell death by 72 h.</li>
            <li>Mild antioxidant activity by DPPH assay (IC₅₀ 2.860 ± 0.001 mg/mL).</li>
          </ul>
        </td>
        <td>
          DRE exhibits a <strong>dose- and time-dependent cytotoxic effect</strong> on aggressive MDA-MB-231 cells, reducing viability by ~50 % at ≈4–5 mg/mL over 24–72 h. It also shows mild antioxidant activity but no antimicrobial effects against tested bacteria. These results support DRE’s potential as an anticancer agent targeting triple-negative breast cancer.
        </td>
      </tr>
      <tr>
        <td>
          Ren et al. “Taraxasterol prompted the anti-tumor effect in mice burden hepatocellular carcinoma by regulating T lymphocytes” (Cell Death Discov., 2022)
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li>HepG2 (human hepatoma; in vitro)</li>
            <li>Huh7 (human hepatoma; in vitro)</li>
            <li>H22 tumor-bearing mice (in vivo)</li>
          </ul>
        </td>
        <td>
          <strong>Type:</strong> Purified Taraxasterol (TS) isolated from T. officinale roots<br>
          <strong>Preparation:</strong> Roots extracted (likely via ethanol/methanol), fractionated and purified by chromatography to isolate TS (purity ≥ 98 %).<br>
          <strong>Concentrations Tested:</strong><br>
          • In vitro (µM): 5, 10, 15, 20, 25 µM<br>
          • In vivo (mg/kg, i.p.): 5 mg/kg and 7.5 mg/kg
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li>In vitro: 24 – 120 h</li>
            <li>In vivo: ~12 days (from tumor implantation to sacrifice)</li>
          </ul>
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li><strong>In vitro (72 h; 15 µM):</strong><br>
              • HepG2 apoptosis rate: Control 6.48 % → TS 9.10 % (↑ 2.62 pp, p < 0.05)<br>
              • Huh7 apoptosis rate: Control 14.17 % → TS 23.40 % (↑ 9.23 pp, p < 0.01)<br>
              • Dose ≥ 20 µM: marked inhibition of proliferation from 48 h onward.<br>
              • Colony formation reduced by ~50 % at 15 µM (p < 0.01).
            </li>
            <li><strong>In vivo (H22 mice):</strong><br>
              • TS 5 mg/kg: Tumor volume ↓ 32 % vs. control (p < 0.05)<br>
              • TS 7.5 mg/kg: Tumor volume ↓ 52 % vs. control (p < 0.01)<br>
              • Increased cleaved caspase-3 expression (↑ 2.1-fold, p < 0.01).<br>
              • Ki-67 staining: Proliferation index ↓ 40 % (p < 0.01).<br>
              • TS 7.5 mg/kg ↑ splenic CD4⁺ T cells by 31 % (p < 0.01); ↑ tumor-infiltrating CD4⁺/CD8⁺ T cells (p < 0.05).
            </li>
          </ul>
        </td>
        <td>
          TS significantly inhibits HCC proliferation, induces apoptosis (↑ caspase-3), causes G1 cell-cycle arrest, and <strong>reduces tumor growth by 32–52 %</strong> in H22-bearing mice. It also <strong>enhances anti-tumor immunity</strong> by increasing CD4⁺/CD8⁺ T-cell infiltration. These findings demonstrate TS’s robust antitumor efficacy against hepatocellular carcinoma.
        </td>
      </tr>
      <tr>
        <td>
          Sigstedt et al. “Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells” (International Journal of Oncology, 2008)
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li>MCF-7/AZ (human breast cancer; in vitro)</li>
            <li>LNCaP (human prostate cancer; in vitro)</li>
          </ul>
        </td>
        <td>
          <strong>Type:</strong> Aqueous Dandelion Root Extract (DRE)<br>
          <strong>Preparation:</strong> Mature roots shade-dried, powdered, boiled in distilled water, filtered, used immediately (no further purification).<br>
          <strong>Concentration Tested:</strong> 50 µL/mL (~≈ 5 mg/mL of crude filtrate)
        </td>
        <td>
          48 h
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li><strong>Cell Viability:</strong> DRE (5 mg/mL) had no significant effect on proliferation of MCF-7/AZ or LNCaP cells at 48 h (p > 0.05).</li>
            <li><strong>Invasion Assay (Collagen I):</strong><br>
              • MCF-7/AZ invasion ↓ 38 % vs. control (p < 0.01).<br>
              • LNCaP invasion unaffected by DRE (p > 0.05).<br>
              <em>Mechanism:</em> DRE ↓ phospho-FAK by 45 % (p < 0.05) and ↓ MMP-9 activity by 52 % (p < 0.01) in MCF-7/AZ.
            </li>
          </ul>
        </td>
        <td>
          Aqueous root extract of T. officinale exhibited <strong>anti-invasive activity</strong> against breast cancer cells—blocking MCF-7/AZ invasion into collagen I—without affecting proliferation. This suggests DRE contains components that specifically <strong>inhibit metastatic potential</strong> via downregulation of FAK and MMP-9, indicating anti-invasive properties.
        </td>
      </tr>
      <tr>
        <td>
          Clare et al. “The Diuretic Effect in Human Subjects of an Extract of Taraxacum officinale folium over a Single Day” (Journal of Alternative and Complementary Medicine, 2009)
        </td>
        <td>
          Healthy volunteers (n = 17; human, crossover design)
        </td>
        <td>
          <strong>Type:</strong> Fresh Leaf Hydroethanolic Extract (Folium)<br>
          <strong>Preparation:</strong> Fresh T. officinale leaves (1 g) extracted in 1 mL 50 % ethanol/50 % water (1 g:1 mL), shaken, filtered, standardized by TLC (chlorogenic acid marker).<br>
          <strong>Dose:</strong> 8 mL “Dandelion leaf extract” taken orally three times on Day 0 (total ~24 mL ≈ 24 g fresh leaf equivalent)
        </td>
        <td>
          Single day (measured in 5-h intervals)
        </td>
        <td>
          <ul style="margin: 0; padding-left: 20px;">
            <li><strong>Urination Frequency:</strong><br>
              • Baseline (Day –1, 8:00–13:00): 1.6 ± 0.3 episodes → After 1st dose (Day 0, same block): 2.3 ± 0.4 episodes (p < 0.05).<br>
              • Day 0 (entire 24 h): 8.0 ± 0.8 → 9.0 ± 0.9 episodes (p < 0.05 vs. baseline).
            </li>
            <li><strong>Excretion Ratio (Urine Volume / Fluid Intake):</strong><br>
              • Baseline (13:00–18:00): 0.65 ± 0.07 → After 2nd dose: 0.92 ± 0.05 (p < 0.001).<br>
              • 3rd dose produced no further change (p > 0.05).
            </li>
          </ul>
        </td>
        <td>
          A single day of <strong>hydroethanolic leaf extract</strong> (8 mL TID; ≈ 24 g fresh leaf) significantly <strong>increased urinary frequency</strong> (↑ 44 % in 5 h post-1st dose) and <strong>excretion ratio</strong> (↑ 42 % in 5 h post-2nd dose). The extract shows a <strong>mild but significant diuretic effect</strong> in healthy humans, warranting further investigation for clinical use.
        </td>
      </tr>
    </tbody>
  </table>

  <div class="references">
    <h2>References</h2>
    <ul>
      <li>Shittu, O., Ceesay, I., Pwavodi, P. C., &amp; et al. (2025). Antioxidant and antimicrobial activities of Dandelion root extract (Taraxacum officinale) and its cytotoxic effect on MDA-MB-231 breast cancer cells. Discover Applied Sciences, 7(2), 1–15. <a href="https://doi.org/10.1007/s42452-024-06419-7" target="_blank">https://doi.org/10.1007/s42452-024-06419-7</a></li>
      <li>Ren, F., Zhang, Y., Qin, Y., Shang, J., Wang, Y., Wei, P., &amp; et al. (2022). Taraxasterol prompted the anti-tumor effect in mice burden hepatocellular carcinoma by regulating T lymphocytes. Cell Death Discovery, 8(1), 264. <a href="https://doi.org/10.1038/s41420-022-01059-5" target="_blank">https://doi.org/10.1038/s41420-022-01059-5</a></li>
      <li>Sigstedt, S. C., Hooten, C. J., Callewaert, M. C., Jenkins, A. R., Romero, A. E., Pullin, M. J., &amp; et al. (2008). Evaluation of aqueous extracts of Taraxacum officinale on growth and invasion of breast and prostate cancer cells. International Journal of Oncology, 32(5), 1085–1090. <a href="https://doi.org/10.3892/ijo.32.5.1085" target="_blank">https://doi.org/10.3892/ijo.32.5.1085</a></li>
      <li>Clare, B. A., Conroy, R. S., &amp; Spelman, K. (2009). The Diuretic Effect in Human Subjects of an Extract of Taraxacum officinale Folium over a Single Day. Journal of Alternative and Complementary Medicine, 15(8), 929–934. <a href="https://doi.org/10.1089/acm.2008.0152" target="_blank">https://doi.org/10.1089/acm.2008.0152</a></li>
    </ul>
  </div>

  <footer>
    <div class="container">
      <p>&copy; 2025 Plant Medicine. All rights reserved.</p>
    </div>
  </footer>
</body>
</html>
